Physician profile
Brian A Long
NPI 1578663779
$773.88
in general payments reported to CMS, 2019-2025
10 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $83.80 · 2024: $271 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $230.69 | 2023-2025 | Nucala |
| Genzyme Corporation | $203.83 | 2023-2025 | |
| Merit Medical Systems INC | $129.50 | 2025 | Esophyx |
| Inspire Medical Systems, INC. | $96.43 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $27.03 | 2025 | Dupixent |
| Medtronic, INC. | $20.59 | 2024 | Fusion |
| Abbott Laboratories | $20.17 | 2024 | Ensite |
| Olympus America INC. | $16.21 | 2024 | Rhino-Laryngo Videoscope |
| Astrazeneca Pharmaceuticals Lp | $15.15 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $14.28 | 2023 | Integra Duo, Integra, Instruments-Orthopedic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.